Sacral nerve stimulation as a treatment for urge incontinence and associated pelvic floor disorders at a pelvic floor center: a follow-up study

Caraballo, Ricardo; Bologna, Raymond; Lukban, James; Whitmore, K. E.

doi:10.1016/s0090-4295(01)01073-1

Cited by 24 publications

(12 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Data collected retrospectively on 36 patients who had SNS for bladder dysfunction and concomitant constipation showed that 28 experienced an increase in bowel frequency and subjective improvement in defaecation (Medtronic, Minneapolis, Minnesota, USA; unpublished data). Other reports of the use of SNS for urge urinary incontinence have also described benefit in patients with constipation 24 . Most published studies of SNS for faecal incontinence have come from specialist centres with a particular interest in the field 25 .…”

Section: Sacral Nerve Stimulationmentioning

confidence: 97%

Systematic review of sacral nerve stimulation for faecal incontinence and constipation

Jarrett

Mowatt

Glazener

et al. 2004

British Journal of Surgery

236

136

View full text Add to dashboard Cite

show abstract

Section: Sacral Nerve Stimulationmentioning

confidence: 97%

Systematic review of sacral nerve stimulation for faecal incontinence and constipation

Jarrett

Mowatt

Glazener

et al. 2004

British Journal of Surgery

236

136

View full text Add to dashboard Cite

show abstract

“…Some investigators report good results with up to 75% improvement in symptoms [77][78][79], including a 20% 'cure' rate [78]. However, follow-up in these studies was short (range 5.6-14 months).…”

Section: Interstitial Cystitismentioning

confidence: 99%

An update on sacral neuromodulation: where do we stand with this in the management of lower urinary tract dysfunction in 2010?

Bosch

2010

BJU International

View full text Add to dashboard Cite

“…Temporary sacral nerve stimulators can be implanted and tested. In one study by Caraballo et al (55), 16 of 17 patients considered the procedure to be a success and would have it done again. In the very severe patients who responded, a permanent sacral nerve stimulator may be implanted.…”

Section: Nerve Stimulationmentioning

confidence: 99%

“…These patients must be very debilitated with their level of discomfort. Surgery usually involves cystectomy with diversion (55). If an augmentation is performed, IC may develop in the neo bladder as well.…”

Section: Surgerymentioning

confidence: 99%

Interstitial cystitis: The great imposter! Epidemiology, etiology, diagnosis and management

Barkin¹

2003

J Sex Reprod Med

373

View full text Add to dashboard Cite

About 115 years ago, the first diagnosis of interstitial cystitis (IC) was offered as a reason to explain the pain related to scarring and inflammation in the bladder. Later, Hunner described the pathognomonic ulcer that bears his name, which is only found in about 5% to 10% of patients with IC. Today, IC is considered a controversial diagnosis. There are still a significant number of clinicians that do not believe in the diagnosis. Some people consider it to be only a diagnosis of exclusion -after every other bladder condition has been ruled out. However, population studies have demonstrated that there is a huge number of patients (mainly female) that fulfill the NIH and/or other diagnostic criteria and deserve the treatment for IC. Frequency, urgency and pain (pelvic and/or voiding) with negative urinary cultures should be considered IC and treated as such. Dyspareunia is one of the commonest complaints of the IC sufferer. The physical, sexual and emotional impact of delayed or misdiagnois of this condition can be devastating or even suicide-provoking in some patients. We now have some excellent, effective and safe intravesical and oral therapies that can provide major relief to a significant number of patients. Il y a environ 115 ans, on a posé le premier diagnostic de cystite interstitielle (CI) comme raison pour expliquer la douleur liée à la cicatrisation et à l'inflammation dans la vessie. Plus tard, Hunner a décrit l'ulcère pathognomonique qui porte son nom : il se manifeste seulement chez environ 5 % à 10 % des patients souffrant de CI. Aujourd'hui, le diagnostic de la CI est controversé. D'ailleurs, il reste encore de nombreux cliniciens qui ne croient pas à ce diagnostic. Pour certains, il s'agit seulement d'un diagnostic d'exclusion -soit après qu'on a éliminé toutes les autres conditions pouvant affecter la vessie. Cependant, des études sur la population ont démontré qu'un nombre très élevé de patients (principalement des femmes) répondent aux critères du NIH et/ou à d'autres critères de diagnostic et méritent de recevoir le traitement contre la CI. La fréquence des épisodes, l'urgence et la douleur (pelvienne et/ou lors de l'élimina-tion) accompagnées de cultures urinaires négatives devraient être associées à la CI et traitées en conséquence. La dyspareunie est l'une des plaintes les plus fréquentes émanant des personnes souffrant d'une CI. Les répercussions physiques, sexuelles et émotionnelles d'un diagnostic retardé ou d'un mauvais diagnostic de cette condition peuvent être dévas-tatrices entraînant même le suicide chez certains patients. Il existe maintenant des traitements intravésicaux et oraux qui peuvent procurer un soulagement majeur à un nombre important de patients. Key

show abstract

Sacral nerve stimulation as a treatment for urge incontinence and associated pelvic floor disorders at a pelvic floor center: a follow-up study

Cited by 24 publications

References 0 publications

Systematic review of sacral nerve stimulation for faecal incontinence and constipation

Systematic review of sacral nerve stimulation for faecal incontinence and constipation

An update on sacral neuromodulation: where do we stand with this in the management of lower urinary tract dysfunction in 2010?

Interstitial cystitis: The great imposter! Epidemiology, etiology, diagnosis and management

Contact Info

Product

Resources

About